March 4, 2022
MARLBOROUGH, Mass. -- Scitara Corporation, an innovator in scientific laboratory digital transformation, announces new releases to its Scitara Digital Lab Exchange DLX™ cloud platform to bring next generation connectivity, self-enabled system configuration, and automation to the lab. Building on the broad based connectivity already available in the Scitara DLX platform, the latest release adds the [...]
FOSS terminates contract with Russian software consultancy group
March 4, 2022
As a consequence of the Russian invasion of the Ukraine, FOSS has decided to suspend all deliveries to Russia (as of 28 February 2022) and to Belarus (as of 4 March 2022). Today, Friday 4 March 2022, this decision is followed by the instant termination of FOSS’ contract with the external Russian software consultancy group, [...]
Oxford Instruments response on the Conflict in Ukraine
March 4, 2022
The Russian attack on Ukraine has shocked the world. As a global company committed to upholding our values of an inclusive, innovative, trusted and purposeful community, Oxford Instruments strongly condemns this unprovoked aggression, which undermines the democracy, sovereignty, and independence of Ukraine. Our thoughts are with the Ukrainian people, and we sincerely hope for a [...]
March 3, 2022
New CellScape™ System Provides Exceptional Quantitative Performance for High-Plex and High-Throughput Targeted Spatial Proteomics ST. LOUIS -- Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumor [...]
World’s first Microhub makes spatial context accessible for all
March 3, 2022
New Mica imaging platform from Leica Microsystems brings previously inaccessible experiments to all life science researchers Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation and a Life Sciences company of Danaher Corporation (NYSE: DHR), has launched Mica, the world’s first Microhub. A Microhub is a new type of wholly integrated imaging [...]
CORRECTING and REPLACING Newomics Announces Collaborations on High-throughput Bioanalysis
March 3, 2022
NEWOMICS ANNOUNCES COLLABORATIONS ON HIGH-THROUGHPUT BIOANALYSIS Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, today announced collaborations with Bruker Corporation, a company with differentiated high-value life science research and diagnostics solutions, on a novel LC-MS platform for drug discovery in the Pharma/Biopharma industry as well as research institutions. The two companies agreed [...]
Avantor Foundation Giving Surpasses $6 Million Since Inception
March 3, 2022
Avantor and Avantor Foundation continue to advance "Science for Goodness" through STEM education and healthcare access Avantor launches associate volunteer programing and continues product donations RADNOR, Penn. -- Avantor Foundation, the philanthropic arm of Avantor, Inc. (NYSE: AVTR), has surpassed $6 million in giving to support greater access to healthcare and advance STEM education since [...]
TWELVE PTR-TOF 1000 FOR SHENZHEN
March 3, 2022
A new PTR-TOF air quality monitoring network in Shenzhen, China In 2019, in accordance with the China development strategy plan, Shenzhen decided to comprehensively enhance the stereoscopic monitoring capabilities supporting environment goals by constructing a pilot demonstration zone. In order to achieve this, Shenzhen Municipal of Ecology and Environment Bureau purchased 12 IONICON PTR-TOF instruments [...]
Qlucore receives second commercial order for new solution
March 3, 2022
The Swedish Nasdaq First North listed software company Qlucore, focused on cancer diagnostics, has signed an agreement with the Molecular Oncohematology Research Group at the Department of Pathology and Experimental Cancer Research at Semmelweis University. The group will use Qlucore’s software to improve diagnostics of acute lymphoblastic leukemia (ALL) and collaborate on a new classification [...]
Biognosys Launches Expanded Suite of Proteomics Platforms to Support Drug Research and Development
March 3, 2022
The TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms provide an integrated suite of research services that reveal deep biological insights from early stage discovery to the clinic. ZURICH – Business Wire. Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the launch of its expanded suite of proteomics platforms that provide pharmaceutical and [...]

